Table:
begin	end	state
1	8	cytoplasmic
9	31	transmembrane
32	53	non-cytoplasmic
54	75	transmembrane
76	86	cytoplasmic
87	112	transmembrane
113	133	non-cytoplasmic
134	154	transmembrane
155	190	cytoplasmic
191	214	transmembrane
215	226	non-cytoplasmic
227	251	transmembrane
252	280	cytoplasmic
281	306	transmembrane
307	321	non-cytoplasmic
322	345	transmembrane
346	358	cytoplasmic
359	384	transmembrane
385	403	non-cytoplasmic
404	425	transmembrane
426	451	cytoplasmic
452	474	transmembrane
475	509	non-cytoplasmic
510	529	transmembrane
530	540	cytoplasmic

Input:
>PP_5195
MPHTPQRRWYLPVSLIAALVLLPLSVLLLSWQSIDLQIWSHLLDTQMGRLLGNTLTLVVG
VGIGVTVLGVSLAWLTSLCDFPGRRWLDWALMLPFAIPAYVLAFVFVGLLDFAGPVQSAL
REVFGPMRLPRVRSTGGVITVLVLVFYPYVYLLARTAFLAQGKGLMEAARVLGLSPLQAF
WRVALPMARPAIGAGIALALMETLADFGAVAVFNFDTFTTAIYKTWYGFFSLSSAAQLAS
LLLLAVMLVLYGERRARGASRSGNERPRAQALYHLRGLKALLASGWCLLVFACAFVIPLL
QLLAWFWQRGRHDLDERYIGLVLHTLYLGSMAALVTVCVALLLAFARRQAPTGGIRAGVG
LANLGYALPGSVLAVSIMLAFSYLDNHLVIPLSSWLGGAGKPLLLGSLSALLLAYLVRFI
AVAYGPLESSLERIRPSLPEASRSLGVGGARLFFKVYLPLLVPGALGAALLVFVDVLKEM
PATLLMRPFGWDTLAVRVFEMTSEGEWARASLPALTLVLVGLLPVIGLIRRSARRPGHSH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server